• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (1)
    • Impact of the controlled release of a connexin 43 peptide on corneal wound closure in an STZ model of type I diabetes.
    • See All Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Impact of the controlled release of a connexin 43 peptide on corneal wound closure in an STZ model of type I diabetes.

Impact of the controlled release of a connexin 43 peptide on corneal wound closure in an STZ model of type I diabetes. PLoS One. 2014; 9(1):e86570.

View in: PubMed

subject areas
  • Animals
  • Biomarkers
  • Blotting, Western
  • Capsules
  • Connexin 43
  • Corneal Diseases
  • Delayed-Action Preparations
  • Diabetes Mellitus, Experimental
  • Diabetes Mellitus, Type 1
  • Enzyme-Linked Immunosorbent Assay
  • Epithelial-Mesenchymal Transition
  • Glucose Transporter Type 4
  • Inflammation
  • Male
  • Peptide Fragments
  • Rats
  • Rats, Sprague-Dawley
  • Real-Time Polymerase Chain Reaction
  • Reverse Transcriptase Polymerase Chain Reaction
  • RNA, Messenger
  • Wound Healing

authors with profiles
  • Jay D Potts